Diagnostic and Interventional Cardiology

First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm

News | Implantable Cardiac Monitor (ICM)

FDA Clears Boston Scientific LUX-Dx Insertable Cardiac Monitor

June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx ...

June 29, 2020

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Cardiac Imaging

MRI Scan Used for Heart Disease Could Also Pick Out Aggressive Cancers

June 29, 2020 — A type of smart magnetic resonance imaging (MRI) scan used in people with heart disease could help ...

June 29, 2020

Abbott OCT intravascular imaging explained.

News | Optical Coherence Tomography (OCT)

OCT Imaging Changed Treatment Decisions in 88 Percent of Artery Blockages in New Study

June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence ...

June 26, 2020

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

The Medtronic Symplicity Spyral renal denervation catheter in the renal artery, showing how its four electrodes contact the vessel wall for a single RF energy delivery procedure. By ablating the vessel walls, it props the vessel in a fully open position, allowing the kidneys to better filter the blood and remove excess water in hypertension patients. RDN

News | Renal Denervation

Simplicity Renal Denervation Lowered Blood Pressure Out to 3 Years

June 26, 2020 – New data from the Global SYMPLICITY Registry (GSR) showed that renal denervation (RDN) with the ...

June 26, 2020

The Foldax Tria surgical valve reimagines the heart valve by incorporating a new, proprietary biopolymer, what the vendor calls LifePolymer, with an innovative valve design intended to eliminate calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants. Tria is also the first heart valve to be robotically manufactured, reducing variability, enabling high precision, repeatability and better quality control.

News | Heart Valve Technology

Foldax Gets $20 Million to Finance Innovative Heart Valve Technology

June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve ...

June 23, 2020

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

News | Defibrillator Monitors

FDA Grants Premarket Clearance for Philips HeartStart FR3 and HeartStart FRx Automated Defibrillators

June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for ...

June 23, 2020

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Navin Kapur, M.D., Tufts Medical Center, shows preCardia device and its anatomical positioning in the patient to treat heart failure..

News | Heart Failure

FDA Grants Breakthrough Device Designation for preCardia Catheter-based Heart Failure Treatment

June 23, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Program status for the ...

June 23, 2020

Signs for "Heroes work here" outside healthcare facilities and even the homes of clinicians have popped up across the country. This photo shows healthcare workers at the Lenox Health emergency room entrance being greeted to cheers and thanks for their essential service during the COVID-19 pandemic in New York City at a public thank you event May 21, 2020. #COVID19 #SARScov2 #pandemic #LenoxHill

Blog | Coronavirus (COVID-19)

Cardiology Stands Up to the COVID-19 Challenge

Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were ...

June 22, 2020

News | Heart Valve Technology

SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device ...

June 19, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | Drug-Eluting Balloons

iVascular Launches Essential Pro Coronary Drug-coated Balloon

June 19, 2020 — iVascular SLU announced the global launch of Essential Pro, a novel coronary artery drug-coated balloon ...

June 19, 2020

MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal coronary angioplasty (PTCA) sirolimus drug-eluting balloon (DEB) for the treatment of coronary artery disease. This includes indications for both de-novo lesions as well as in-stent restenosis. The approval applies to a broad range of balloon sizes, from 1.5 x 10 mm, up to 5 x 40 mm.

News | Drug-Eluting Balloons

MedAlliance Sirolimus Drug Eluting Balloon Gains Second European CE Mark

June 17, 2020 — MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal ...

June 18, 2020

he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care. The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.

News | Peripheral Artery Disease (PAD)

Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

June 16, 2020

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Biotronik Launchs His-Bundle Pacing Tools

News | Pacemakers

Biotronik Launches His-Bundle Pacing Tools

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

June 16, 2020

Health Canada and the U.S. Food and Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide.

News

FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

June 16, 2020

The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19

June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that ...

June 15, 2020